Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pfizer europe ma eeig, belgium - polysaccharide for serotypes 1, 3, 4, 5, 6a, 7f, 8, 9v, 10, 11a, 12f, 14, 15b, 18c, 19a, 19f, 22f, 23f, 33f,polysaccharide for serotypes 6b,crm197 protein - suspension for injection - 2.2,4.4,51 µg,

Saudiarabien - engelska - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pfizer europe ma eeig, belgium - polysaccharide for serotypes 1, 3, 4, 5, 6a, 7f, 8, 9v, 10, 11a, 12f, 14, 15b, 18c, 19a, 19f, 22f, 23f, 33f,polysaccharide for serotypes 6b,crm197 protein - suspension for injection - 2.2,4.4,51 µg,

Armenien - engelska - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

pfizer manufacturing belgium nv - pneumococcal polysaccharide conjugate vaccine (pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide serotype 3, pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6a, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide serotype 14, pneumococcal polysaccharide serotype 18c, pneumococcal polysaccharide serotype 19a, pneumococcal pol - suspension for injection - 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 4.4mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose+ 2.2mcg/dose

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - methotrexate, quantity: 500 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid; sodium hydroxide - antineoplastic chemotherapy - treatment of breast cancer, gestational choriocarcinoma and in patients with chorioadenoma destruens and hydatidiform mole. palliation of acute and subacute lymphocytic and meningeal leukaemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukaemia. in combination with corticosteroids, methotrexate may be used for induction of remission. the drug is now most commonly used for the maintenance of induced remissions. methotrexate is also effective in the treatment of the advanced stages (iii and iv, peters staging system) of lymphosarcoma, particularly in children and in advanced cases of mycosis fungoides. high dose therapy - the use of very high doses is made possible by vials for injection containing 500 mg and 1000 mg (see precautions). diseases treated with these doses administered in the form of single-drug or combination therapy, include osteogenic sarcoma, acute leukaemia, bronchogenic carcinoma and epidermoid carcinoma of the head and n

Australien - engelska - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - daunorubicin, quantity: 20 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - indications as at 22 november 2004 : daunorubicin injection is indicated for the treatment of the following: acute lymphocytic (lymphoblastic) leukaemia: daunorubicin is usually reserved for use in cases shown to be resistant to other drugs. however, combined treatment with daunorubicin, vincristine and a steroid has been used in the early stages of this disease. acute myeloblastic leukaemia: daunorubicin has been used in all stages, alone or in combination with other cytotoxic agents (e.g. cytarabine). disseminated solid tumours: daunorubicin has been investigated for use in these tumours and found to be effective in some cases of disseminated neuroblastoma and rhabdomyosarcoma.

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - etanercept - etanercept....50 mg/ml

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - etanercept - etanercept....50 mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig. - axitinib - axitinib....5.00mg

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - neisseria meningitidis serogrupo b fhbp subfamilia a - neisseria meningitidis serogrupo b fhbp subfamilia a....60 mcg. / neisseria meningitidis serogrupo b fhbp subfamilia b....60 mcg.

Panama - engelska - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - sunitinib (malato) - sunitinib (malato)....50 mg